SAVARINO, EDOARDO VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 20.326
EU - Europa 1.909
AS - Asia 1.084
AF - Africa 23
SA - Sud America 19
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 23.368
Nazione #
US - Stati Uniti d'America 20.306
CN - Cina 729
IT - Italia 646
FI - Finlandia 399
GB - Regno Unito 248
VN - Vietnam 211
DE - Germania 210
SE - Svezia 155
UA - Ucraina 62
IN - India 49
IE - Irlanda 44
FR - Francia 36
NL - Olanda 21
CA - Canada 15
HK - Hong Kong 14
RU - Federazione Russa 13
IR - Iran 12
NO - Norvegia 12
PH - Filippine 11
TR - Turchia 10
ES - Italia 8
ET - Etiopia 8
ID - Indonesia 8
JP - Giappone 8
PL - Polonia 8
CH - Svizzera 7
BR - Brasile 6
EG - Egitto 6
KR - Corea 6
PK - Pakistan 6
PT - Portogallo 6
RO - Romania 6
CO - Colombia 5
BE - Belgio 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
IQ - Iraq 4
SG - Singapore 4
AT - Austria 3
AU - Australia 3
BG - Bulgaria 3
EU - Europa 3
MY - Malesia 3
NG - Nigeria 3
PE - Perù 3
PY - Paraguay 3
TW - Taiwan 3
BD - Bangladesh 2
BY - Bielorussia 2
CL - Cile 2
CU - Cuba 2
GR - Grecia 2
HN - Honduras 2
LS - Lesotho 2
LU - Lussemburgo 2
LY - Libia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BW - Botswana 1
CI - Costa d'Avorio 1
HU - Ungheria 1
IL - Israele 1
LT - Lituania 1
MQ - Martinica 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RS - Serbia 1
Totale 23.368
Città #
Fairfield 4.245
Woodbridge 2.097
Houston 1.959
Ashburn 1.588
Seattle 1.511
Cambridge 1.451
Wilmington 1.240
Ann Arbor 1.175
Chandler 1.134
San Diego 555
Princeton 458
Medford 372
Des Moines 293
Beijing 265
Helsinki 226
Roxbury 217
Dong Ket 205
Jacksonville 157
Padova 151
Nanjing 100
Boardman 96
London 84
New York 51
Ogden 45
Falls Church 44
Milan 40
Dublin 39
Nanchang 35
Shenyang 33
Norwalk 32
Jiaxing 29
Hebei 28
Kharkiv 27
Guangzhou 25
Kilburn 21
Tianjin 21
Changsha 20
Pune 20
Indiana 19
Rome 19
Chicago 15
Redwood City 15
Borås 14
Jinan 13
Lappeenranta 13
Prescot 13
New Bedfont 12
Shanghai 12
Washington 12
Las Vegas 10
Chiswick 9
Fort Wayne 9
Hounslow 9
Los Angeles 9
Zhengzhou 9
Abbiategrasso 8
Bergen 8
Berlin 8
Campodarsego 8
Florence 8
Paris 8
Solihull 8
Turin 8
Acton 7
Islington 7
Manila 7
Naples 7
Phoenix 7
Reggio Nell'emilia 7
Rockville 7
San Francisco 7
Tappahannock 7
Vicenza 7
San Martino Buon Albergo 6
Southwark 6
Verona 6
Amsterdam 5
Curtarolo 5
Ha Kwai Chung 5
Istanbul 5
La Spezia 5
Lettomanoppello 5
Menlo Park 5
Orange 5
Redmond 5
Venice 5
Falkenstein 4
Gavirate 4
Haikou 4
Hangzhou 4
Hanoi 4
Hefei 4
Hong Kong 4
Kish 4
Lanuvio 4
Medellín 4
Oldenburg 4
Palermo 4
Pittsburgh 4
Prague 4
Totale 20.559
Nome #
Effects of laparoscopic myotomy on the esophageal motility pattern of esophageal achalasia as measured by high-resolution manometry 190
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. 171
Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study 165
The natural history of achalasia: Evidence of a continuum-"The evolutive pattern theory" 146
Superior Mesenteric Artery Syndrome: a Prospective Study in a Single Institution 140
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 134
Effects of omega-loop bypass on esophagogastric junction function 129
The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon 129
Modern diagnosis of GERD: the Lyon Consensus 129
The Chicago Classification of esophageal motility disorders, v3.0 120
Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control study 120
Noncoding RNAs as drivers of the phenotypic plasticity of oesophageal mucosa 115
Fecal calprotectin in systemic sclerosis: Light and shade of a promising tool 111
Indications and interpretation of esophageal function testing 111
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. 109
Measurement of oro-caecal transit time by magnetic resonance imaging. 108
Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease 108
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 108
Adalimumab trough levels and response to biological treatment in patients with inflammatory bowel disease: A useful cutoff in clinical practice 102
Comment on "Impairment of chemical clearance is relevant to the pathogenesis of refractory reflux oesophagitis" by Marzio Frazzoni et al. [Digestive and Liver Disease 2014;46:596-602] 102
Achalasia with dense eosinophilic infiltrate responds to steroid therapy. 101
Low serum trough levels are associated with post-surgical recurrence in Crohn's disease patients undergoing prophylaxis with adalimumab 101
The Impact of Heller Myotomy on Integrated Relaxation Pressure in Esophageal Achalasia 101
The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal 101
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 101
OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients 101
Optimal number of multiple rapid swallows needed during high-resolution esophageal manometry for accurate prediction of contraction reserve 101
Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement 101
Normal values of esophageal motility after antireflux surgery; a study using high-resolution manometry 99
Achalasia and Obstructive Motor Disorders Are Not Uncommon in Patients With Eosinophilic Esophagitis 99
A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. 98
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. 98
Influence of Diet on the Course of Inflammatory Bowel Disease 97
Proton pump inhibitor failure: why does it occur and how can it be managed? 96
Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease. 96
Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. 95
Nonerosive reflux disease: Clinical concepts 95
There is much more to rely on histology than the sole endoscopy tells us 95
A Comparison Between Lactose Breath Test and Quick Test on Duodenal Biopsies for Diagnosing Lactase Deficiency in Patients With Self-reported Lactose Intolerance. 94
Nonerosive reflux disease and functional heartburn are clearly separate entities. 94
Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. 93
The appropriate use of proton-pump inhibitors 93
The reason for failure of on-demand PPI therapy in NERD patients. 92
In-vivo Axial-strain Sonoelastography Helps Distinguish Acutely-inflamed from Fibrotic Terminal Ileum Strictures in Patients with Crohn's Disease: Preliminary Results 92
Between GERD and NERD: the relevance of weakly acidic reflux 92
The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring 92
Arterial congestive gastropathy: A new entity? 91
Quality of life after laparoscopic sigmoid resection for uncomplicated diverticular disease 91
Combined multichannel intraluminal impedance and manometry testing. 90
The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders 89
The natural history of gastro-esophageal reflux disease: a comprehensive review 89
Classification of esophageal motor findings in gastro-esophageal reflux disease: Conclusions from an international consensus group 89
REAL LIFE COMPARISON OF DIFFERENT ANTI-TNF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS TREATMENT: A RETROSPECTIVE COHORT STUDY 89
Expert consensus document: Advances in the physiological assessment and diagnosis of GERD 89
Esophageal biopsies in the management of GERD: Complementary tool for many but not for all 88
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD 88
Eosinophilic esophagitis: Latest insights from diagnosis to therapy 88
Clinical, endoscopic, histological and radiological characteristics of Italian patients with eosinophilic oesophagitis 87
Ultrasound-guided procedures around the wrist and hand: How to do. 87
Symptom association analysis is important in GERD patients undergoing endoscopic therapy 86
Anti-Tumor Necrosis Factor Antibodies for Prevention of Crohn's Disease Recurrence After Surgery: More Than a Hope 86
Current and future perspectives in the management of gastroesophageal reflux disease 86
Helicobacter pylori and tolerance to H2-blockers. 85
Ultrasound assessment of the rotator cuff cable: comparison between young and elderly asymptomatic volunteers and interobserver reproducibility. 85
Validation of criteria for the definition of transient lower esophageal sphincter relaxations using high-resolution manometry 85
Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease. 85
Functional testing: pharyngeal pH monitoring and high-resolution manometry. 84
Letter: proton pump inhibitor-responsive oesophageal eosinophilia – more than just gastro-oesophageal reflux disease. Authors' reply 84
Infliximab trough levels and persistent vs transient antibodies measured early after induction predict long-term clinical remission in patients with inflammatory bowel disease 84
Matrix Metalloproteinase 3 Predicts Therapeutic Response in Inflammatory Bowel Disease Patients Treated With Infliximab 84
Non-erosive reflux disease patients are more complex than the sole endoscopy tells us. 83
Functional heartburn and non-erosive reflux disease. 82
NERD: an umbrella term including heterogeneous subpopulations. 82
Letter: treatment for small intestinal bacterial overgrowth - where are we now? 82
Caution About Overinterpretation of Number of Reflux Episodes in Reflux Monitoring for Refractory Gastroesophageal Reflux Disease 82
Are proton pump inhibitors really so dangerous? 82
Ilaprazole for the treatment of gastro-esophageal reflux 82
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease 82
Comment to "current applications of evolving methodologies in gastroesophageal reflux disease testing". 81
Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution. 81
Gastrointestinal motility disorder assessment in systemic sclerosis. 81
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment. 81
The importance of subgrouping refractory NERD patients according to esophageal pH-impedance testing. 81
Optimal management of constipation associated with irritable bowel syndrome 81
Bowel Sonoelastography in Patients with Crohn's Disease: A Systematic Review 81
Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. 80
Modulation of inflammation in IBD: Alpha7nAChR expression and role of nicotine 80
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 80
Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn 80
Association Between Baseline Impedance Values and Response Proton Pump Inhibitorsin Patients With Heartburn. 80
Factors Influencing Disability and Quality of Life during Treatment: A Cross-Sectional Study on IBD Patients 80
Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial. 79
A more in-depth evaluation of impedance-pH could assist in distinguishing reflux-related from reflux-unrelated heartburn 79
Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis 79
Factors associated with disability in patients with ulcerative colitis: A cross-sectional study 79
Air swallowing can be responsible for non-response of heartburn to high-dose proton pump inhibitor. 78
An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. 78
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment 78
The relevance of symptom association analysis in GORD patients undergoing anti-reflux surgery. 77
Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring 77
Totale 9.562
Categoria #
all - tutte 109.004
article - articoli 108.870
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 217.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.768 0 0 0 0 0 0 0 0 0 375 746 647
2019/20204.577 546 169 70 382 501 301 417 473 547 608 385 178
2020/20214.284 368 152 369 334 187 302 385 364 567 479 294 483
2021/20226.157 284 611 666 364 607 304 403 589 544 170 478 1.137
2022/20233.013 732 132 91 352 424 407 28 189 335 57 201 65
2023/20241.705 125 245 207 177 173 211 209 167 141 50 0 0
Totale 23.929